Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)
Clinical trial NCT03379506 · COMPLETED
Trial details
- NCT number
- NCT03379506
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-25
- Primary completion
- 2019-10-28
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.